Skip to Main Content

Paper Details

Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity.
Nature
161
2021
Author NameAffiliation
Gabriel K GriffinBroad Institute of MIT and Harvard
Gabriel K GriffinBrigham and Women's Hospital and Harvard Medical School
Gabriel K GriffinDepartment of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School
Malvina PapanastasiouBroad Institute of MIT and Harvard
Jacob D JaffeBroad Institute of MIT and Harvard
Jacob D Jaffe
Steven A CarrBroad Institute of MIT and Harvard
Steven A CarrBroad Institute of MIT and Harvard
John G DoenchBroad Institute of MIT and Harvard
Bradley E BernsteinBroad Institute of MIT and Harvard
Bradley E BernsteinDepartment of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School
Bradley E BernsteinBroad Institute of MIT and Harvard
Bradley E BernsteinDepartment of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School
  • 1 - 13

Datasets

Release 1.2